Incidence of hypoglycaemia in patients with type 2 diabetes mellitus recently initiating basal insulin in a real-world US setting

被引：0
|
作者：
Kazemi, M. [1 ]
Ye, F. [1 ]
Dalal, M. R. [1 ]
机构：
[1] Sanofi US Inc, Bridgewater, MA USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
949
引用
收藏
页码：S458 / S458
页数：1
相关论文
共 50 条
  • [1] Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
    Davis, Keith L.
    Tangirala, Muralikrishna
    Meyers, Juliana L.
    Wei, Wenhui
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1083 - 1091
  • [2] Real-world comparative outcomes study in US patients with type 2 diabetes initiating basal insulin analogues
    Davis, K. L.
    Meyers, J. L.
    Tangirala, M.
    Wei, W.
    [J]. DIABETOLOGIA, 2012, 55 : S384 - S384
  • [3] Demographic and clinical profiles of type 2 diabetes mellitus patients initiating sitagliptin in the real-world setting
    Pawaskar, Manjiri
    Liu, Jinan
    Rajpathak, Swapnil
    Iglay, Kristy
    Engel, Samuel S.
    Hannachi, Hakima
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (07) : 1247 - 1253
  • [4] First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
    Tsai, Shih-Tzer
    Pathan, Faruque
    Ji, Linong
    Yeung, Vincent Tok Fai
    Chadha, Manoj
    Suastika, Ketut
    Son, Hyun Shik
    Tan, Kevin Eng Kiat
    Benjasuratwong, Yupin
    Thy Khue Nguyen
    Iqbal, Farrukh
    [J]. JOURNAL OF DIABETES, 2011, 3 (03) : 208 - 216
  • [5] Risk factors and economic burden of hypoglycaemia in patients with type 2 diabetes mellitus initiating basal insulin in a US managed care system
    Gerrits, C.
    Chou, E.
    Chung, H. -W.
    Wang, H.
    Zhang, Q.
    [J]. DIABETOLOGIA, 2014, 57 : S203 - S204
  • [6] Initiating basal insulin therapy in patients with type 2 diabetes mellitus
    Stoneking, K
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 510 - 518
  • [7] Clinical and economic outcomes among injection-naive patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
    Mody, Reema
    Huang, Qing
    Yu, Maria
    Patel, Hiren
    Zhang, Xian
    Wang, Liya
    Grabner, Michael
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [8] Hypoglycaemia association with hospitalisation and mortality in older patients with type 2 diabetes mellitus initiating Basal Insulin (BI) in a US medicare advantage population
    Escalada, J.
    Liao, L.
    Pan, C.
    Wang, H.
    Bala, M.
    [J]. DIABETOLOGIA, 2015, 58 : S61 - S61
  • [9] Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
    Bellido, Diego
    Abellan, Pablo
    Palomar, Jose Manuel Ruiz
    Sintes, Rogelio Alvarez
    Nubiolae, Andreu
    Bellido, Virginia
    Romero, Gracia
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2018, 89 : 37 - 42
  • [10] Risk factor and economic burden of hypoglycaemia in elderly patients with type 2 diabetes mellitus initiating Basal Insulin (BI) in a US medicare advantage population
    Liao, L.
    Wang, H.
    Pan, C.
    Bala, M.
    Escalada, J.
    [J]. DIABETOLOGIA, 2015, 58 : S410 - S411
12345